The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Navratri aligns each of its nine days with specific forms of Goddess Durga and their corresponding planetary energies. By focusing on unique spiritual practices each day, individuals can balance ...

Protos has created a chart of fundamental metrics of Solana’s blockchain since ... With the price of TRUMP down 85% in two months, there are apparently fewer reasons to use Solana these days. Indeed, ...

Traditions and Celebrations in Kerala Jaat Box Office Collection Day 2: Sunny Deol’s Film Struggles to Draw Crowds, Earns ₹15 Crore in 2 Days ...

Coca-Cola, Pepsi Max and Velvet toilet rolls are among the surprise bestsellers in Amazon’s Spring Deal Days event. Here’s what shoppers are really buying. Did you know with a Digital ...

Auraiya: A man was allegedly killed by a contract killer hired by his wife and her lover in Uttar Pradesh's Auraiya district, the police said. The accused -- 22-year-old Pragati Yadav, her lover ...

Samsung will release One UI 7, which contains Android 15 operating software, for a tranche of Galaxy smartphones, including the S24 series, in April 2025. A few days ago, the April 10 release date ...

Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data presented Thursday at the Advanced Technologies & Treatments for Diabetes conference. Dexcom pointed ...

Indian Idol 15 has kept viewers hooked to the screen with enthralling performances so far. While the show is slowly gearing towards its finale, fans have been excited to learn which participants will ...

As Congress gears up to pass President Trump’s massive legislative package, one of the biggest fights is over the future of Medicaid. To make their targeted budget numbers, Republicans will ...

The Dexcom 15-day G7 continuous glucose monitor (CGM) is accurate and safe for use up to 15.5 days in adults with diabetes. Currently under review by the US Food and Drug Administration ...

The 15.5-day Dexcom G7 continuous glucose monitor (CGM) demonstrated high accuracy and safety in adults with diabetes, meeting and exceeding integrated CGM performance goals.